{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Understanding the Pathophysiology, Implications, and Treatment Options of Patent Ductus Arteriosus in the Neonatal Population

Description

This article has been approved by the National Association for Neonatal Nurses Certification Board for Category B credit toward recertification as an NNP.

Purpose of Activity

To provide information on the pathophysiology and treatment options for patent ductus arteriosus (PDA).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify the pathophysiology and clinical manifestations of PDA.
  2. Specify the diagnosis of and treatment options for an infant with PDA.
Price: $17.95

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: ANC0619
Published: June 2019
Expires: 6/4/2021
Passing Score: 12/17 (70%)
Authors: Cristin Conrad, BSN, CCRN-NICU; Desi Newberry, DNP, NNP-BC